David Barros-Aguirre

Also affiliated with GMV Innovating Solutions (Spain)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial”.

A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial

Nature Medicine(2024)10.1038/s41591-024-02829-7

N/A

1.3DataRank · unranked

50 citations

Clifton E. Barry, Alex Carlton, Ray Y. Chen, Matt Davies, Veronique de Jager +14 more

Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis

Drug Resistance Updates(2025)10.1016/j.drup.2025.101213

N/A

0.425DataRank · unranked

9 citations

Rubén González del Río, María Pilar Arenaz-Callao, Helena I. Boshoff, Joaquín Rullás, Sara Anca +10 more

Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.10.617558

N/A

0.108DataRank · unranked

1 citations

Rubén González del Río, María Pilar Arenaz-Callao, Helena I. Boshoff, Joaquín Rullás, Sara Anca +10 more

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions

ACS Infectious Diseases(2022)10.1021/acsinfecdis.1c00570

N/A

0DataRank · unranked

25 citations

Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood +39 more

The Tuberculosis Drug Accelerator at year 10: what have we learned?

Nature Medicine(2021)10.1038/s41591-021-01442-2

N/A

0DataRank · unranked

62 citations

David Barros-Aguirre, Clifton E. Barry, Robert H. Bates, Steven J. Berthel, Helena I. Boshoff +32 more

Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01459-22

N/A

0DataRank · unranked

20 citations

Rubén González del Río, Mónica Cacho, David Barros-Aguirre, Joël Lelièvre, Joaquín Rullás +7 more

A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Antimycobacterial Activity

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.02420-20

N/A

0DataRank · unranked

41 citations

Rubén González del Río, Mónica Cacho-Izquierdo, Fátima Ortega, Joël Lelièvre, David Barros-Aguirre +5 more

A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01514-21

N/A

0DataRank · unranked

23 citations

Rubén González del Río, Mónica Cacho-Izquierdo, Fátima Ortega, Joël Lelièvre, David Barros-Aguirre +7 more